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Background: Redox-cofactor balancing constrains product yields in anaerobic fermentation processes. This
challenge is exemplified by the formation of glycerol as major by-product in yeast-based bioethanol production,
which is a direct consequence of the need to reoxidize excess NADH and causes a loss of conversion efficiency.
Enabling the use of CO2 as electron acceptor for NADH oxidation in heterotrophic microorganisms would increase
product yields in industrial biotechnology.
Results: A hitherto unexplored strategy to address this redox challenge is the functional expression in yeast of
enzymes from autotrophs, thereby enabling the use of CO2 as electron acceptor for NADH reoxidation. Functional
expression of the Calvin cycle enzymes phosphoribulokinase (PRK) and ribulose-1,5-bisphosphate carboxylase
(Rubisco) in Saccharomyces cerevisiae led to a 90% reduction of the by-product glycerol and a 10% increase in
ethanol production in sugar-limited chemostat cultures on a mixture of glucose and galactose. Co-expression of the
Escherichia coli chaperones GroEL and GroES was key to successful expression of CbbM, a form-II Rubisco from the
chemolithoautotrophic bacterium Thiobacillus denitrificans in yeast.
Conclusions: Our results demonstrate functional expression of Rubisco in a heterotrophic eukaryote and
demonstrate how incorporation of CO2 as a co-substrate in metabolic engineering of heterotrophic industrial
microorganisms can be used to improve product yields. Rapid advances in molecular biology should allow for rapid
insertion of this 4-gene expression cassette in industrial yeast strains to improve production, not only of 1st and
2nd generation ethanol production, but also of other renewable fuels or chemicals.
Keywords: Metabolic engineering, Synthetic biology, Rubisco, Ribulose-1,5-bisphosphate carboxylase,
Phosphoribulokinase, NADH re-oxidation, Carbon dioxide fixation, Saccharomyces cerevisiae, Glycerol, BioethanolBackground
The yeast Saccharomyces cerevisiae is not only used for the
large-scale production of fuel ethanol [1], but also for in-
dustrial production of a broad and rapidly expanding range
of other chemical compounds from renewable carbo-
hydrate feedstocks [2,3]. In anaerobic, ethanol-producing
cultures of S. cerevisiae, excess NADH generated from
biosynthetic reactions, such as NAD+-dependent oxidative
decarboxylations involved in synthesis of the precursors
acetyl-CoA and 2-oxoglutarate, is reoxidized by reducing
part of the sugar substrate to glycerol [4]. In growing* Correspondence: A.J.A.vanMaris@tudelft.nl
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distribution, and reproduction in any mediumanaerobic yeast cultures, glycerol production typically ac-
counts for 4-10% of the total sugar consumption and
therefore has a significant impact on ethanol yields and
process economy in both 1st and 2nd generation large-
scale bioethanol production [5,6].
Using CO2 as electron acceptor for the reoxidation of
NADH would be a highly attractive metabolic engineering
strategy, in particular when CO2 reduction can be coupled
to the formation of the product of interest. Functional ex-
pression of the Calvin cycle enzymes phosphoribulokinase
(PRK) and ribulose-1,5-bisphosphate carboxylase (Rubisco)
in S. cerevisiae should enable the coupling of CO2, a major
product of alcoholic fermentation, to ribulose-5-phosphate,
a normal intermediate of the S. cerevisiae pentose-
phosphate pathway (Figure 1). The resulting two molecules
of 3-phosphoglycerate can subsequently be converted to 2ed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Schematic representation of central carbon metabolism and the introduced Calvin-cycle enzymes in Saccharomyces cerevisiae.
Orange: Formation of biomass and NADH from glucose and NADPH. Stoichiometries are according to Verduyn et al. [7]; Blue: Redox-neutral,
ATP-yielding alcoholic fermentation of glucose and galactose via the Embden-Meyerhof-Parnas glycolysis and Leloir pathways, respectively;
Magenta: NADPH generation via the oxidative part of the pentose-phosphate pathway; Green: rearrangement of sugar-phosphate carbon
skeletons via the non-oxidative pentose-phosphate pathway; Black: NADH oxidation by formation of glycerol through glycerol-3-phosphate
dehydrogenase and glycerol-3-phosphatase; Red: heterologously expressed Calvin-cycle enzymes phosphoribulokinase and Rubisco. Numbers in
boxes represents the distribution of carbon along the different pathways (in mmol) normalized for a combined glucose and galactose uptake of
100 mmol for a wild-type, glycerol-producing reference strain (top) and for a scenario in which the alternative pathways via the Calvin cycle
enzymes completely replace glycerol formation as the mechanism for reoxidizing NADH formed in biosynthetic reactions (bottom). In the
scenario with the Calvin cycle enzymes, ribulose-5-phosphate was assumed to be preferentially derived from the oxidative reactions of the
pentose phosphate pathway. Once the generation of NADPH from these reactions matched the requirement for NADPH in biosynthesis, further
ribulose-5-phosphate was derived from glycolytic intermediates via the non-oxidative pentose-phosphate pathway rearrangement reactions. The
biomass yield on ATP was assumed to be identical for both scenarios.
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tant net oxidation of 2 molecules of NADH to NAD+
(Figure 1). When ribulose-5-phosphate is formed via
the oxidative pentose-phosphate pathway (Figure 1),
this route results in a transhydrogenase-type conversion
of redox cofactors (NADP+ + NADH→NADPH+NAD+).
Since the total amount of NADPH required in biosynthesis
is smaller than the amount of NADH generated [7], such a
transhydrogenase-like activity cannot fully replace glycerol
formation as a mechanism for reoxidizing biosyntheticNADH. However, no such constraint exists when ribulose-
5-phosphate is formed from intermediates of glycolysis via
the rearrangement reactions of the non-oxidative pentose-
phosphate pathway (Figure 1). A theoretical analysis shows
that complete replacement of glycerol production with
CO2 incorporation through PRK and Rubisco can increase
the ethanol yield of sugar by as much as 14% (Figure 1).
The PRK gene from Spinacia oleracea [8] has previ-
ously been expressed in the yeast Pichia pastoris [9] and
is therefore an interesting candidate for heterologous
Figure 2 Rubisco enzymatic activity in S. cerevisiae strains
expressing different synthetic constructs. Specific ribulose-1,5-
bisphosphate carboxylase (Rubisco) activity in cell extracts of
S. cerevisiae expressing Rubisco form II CbbM from T. denitrificans,
either alone (IMC033) or in combination with the E. coli chaperones
GroEL/GroES [18] (IMC035), the T. denitrificans chaperones
CbbO2/CbbQ2 [20] (IMC034) or all four chaperones (IMC014).
Heterologously expressed genes were codon optimised for
expression in yeast and expressed from a single centromeric vector.
Biomass samples were taken from anaerobic batch cultures on
synthetic media (pH 5.0, 30°C), sparged with nitrogen and
containing 20 g l-1 glucose as carbon source. Rubisco activities,
measured as 14CO2-fixation in cell extracts, in a wild-type reference
strain and in S. cerevisiae strains expressing cbbM and cbbM-cbbQ2-
cbbO2 were below the detection limit of the enzyme assay
(0.2 nmol CO2 min
-1 mg protein-1).
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the Calvin cycle for autotrophic carbon fixation, three
catalytically active forms have been described [10,11]. Pro-
karyotic form-II Rubisco’s are encoded by single structural
genes and several have been heterologously expressed in
E. coli [12,13]. Functional expression of form-II Rubisco’s
in E. coli was shown to be strongly stimulated by the
E. coli protein-folding chaperones GroEL and GroES [14]
and expression of Hydrogenovibrio marinus Rubisco in
E. coli was further stimulated by co-expression of the
CbbO and CbbQ chaperones of the donor organism [15].
Very recently the structure of GroEL/GroES encapsulating
Rubisco was visualized by cryo-electron microscopy [16].
Eukaryotes such as S. cerevisiae harbour a chaperone
couple (Hsp60/Hsp10) that structurally and functionally
resemble GroEL/GroES. However, these proteins are lo-
cated in the mitochondria, whereas a role in Rubisco ex-
pression would require their activity in the cytosol.
In this study we investigated how to achieve functional
expression of PRK and Rubisco in yeast. In view of the
envisioned benefit of being encoded by single structural
genes, a prokarytic form-II Rubisco gene was expressed
in S. cerevisiae in combination with the PRK gene from
Spinacia oleracea. Both the promoters and coding re-
gions for genes required for glycerol formation were
left unchanged compared to the reference strain. Subse-
quently, the impact of the resulting CO2 incorporation
on product formation was studied, with special emphasis
on the yields of ethanol and the undesired by-product
glycerol.
Results and discussion
Chaperone-mediated functional expression of Rubisco in
Saccharomyces cerevisiae
To study a possible requirement of heterologous chaper-
ones for expression of Rubisco in S. cerevisiae, the form-
II Rubisco-encoding cbbM gene from T. denitrificans
[17] was codon-optimised for expression in S. cerevisiae
and expressed from a centromeric vector, both alone
and in combination with expression cassettes for the
codon-optimised E. coli groEL/groES [18] and/or T.
denitrificans cbbO2/cbbQ2 genes [19,20]. Functional ex-
pression of T. denitrificans Rubisco in S. cerevisiae, as
indicated by ribulose-1,5-bisphosphate-dependent 14CO2
fixation by yeast cell extracts, was only observed upon
co-expression of E. coli GroEL/GroES (Figure 2). Co-
expression of CbbO2/CbbQ2 did not result in a further
increase of Rubisco activity (Figure 2). Co-expression of
bacterial chaperones has previously been shown to im-
prove heterologous protein expression in Pichia pastoris
and insect cells [21,22]. The positive effect of GroEL/
GroES on Rubisco expression in S. cerevisiae demon-
strates the potential value of co-expression of heterol-
ogous chaperones for metabolic pathway engineeringthat requires expression of prokaryotic enzymes in the
cytosol of eukaryotes.
Functional expression of phosphoribulokinase in
Saccharomyces cerevisiae
The Spinacia oleracea phosphoribulokinase (PRK) gene
[8], which has previously been expressed in the yeast
Pichia pastoris [9], was integrated together with E. coli
groEL/groES and T. denitrificans cbbO2/cbbQ2 into the
S. cerevisiae genome at the CAN1 locus, under control
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high PRK activities (approximately 15 μmol mg protein-1
min-1) in cell extracts of S. cerevisiae strain IMU033 taken
from carbon-limited chemostat cultures on a mixture of
glucose and galactose (Table 1). Although relatively high
background activities were measured in the reference
strain without PRK (IMU032), this activity does not con-
tribute to pathway activity (see below). We therefore as-
sumed that the background activity observed in the
reference strain was caused by an impurity in one of
the chemicals used in the assay and did not reflect forma-
tion of ribulose-1,5-bisphosphate. The engineered strain
IMU033, which additionally carried the centromeric ex-
pression cassette for T. denitrificans Rubisco, was used to
quantitatively analyse the physiological impacts of the ex-
pression of Rubisco and PRK.Carbon dioxide as electron acceptor in anaerobic
chemostat cultures of Saccharomyces cerevisiae
Quantitative physiological analysis is facilitated by the
constant and highly reproducible process conditions in
steady-state chemostat cultures [23,24]. Therefore, ethanol
and glycerol yields of PRK- and Rubisco-expressing S.
cerevisiae were compared to those of an isogenic reference
strain in anaerobic, sugar-limited chemostats on a mixture
of 12.5 g l-1 glucose and 12.5 g l-1 galactose. In nitrogen-
sparged cultures, the glycerol yield on sugar in the strain
expressing both Calvin-cycle enzymes was 68% lower than
in the reference strain, while ethanol and biomass yields
on sugar were 11% and 12% higher, respectively (Table 1).
To investigate whether the low affinity of T. denitrificans
form-II Rubisco for CO2 (KCO2 = 0.26 mM [17]) limitedTable 1 Physiological analysis of S. cerevisiae IMU033 express
IMU032 in anaerobic chemostat cultures, grown at a dilution
supplemented with 12.5 g l-1 glucose and 12.5 g l-1 galactose
IMU032
(Reference strain)
CO2 in inlet gas (%) 0
CO2 in outlet gas (%) 0.89 ± 0.03 10
Phosphoribulokinase
(μmol mg protein-1 min-1) 0.58 ± 0.09 0.5
Rubisco
(nmol mg protein-1 min-1)
< 0.2*
Biomass yield on sugar
(g g-1)
0.083 ± 0.000a 0.08
Ethanol yield on sugar
(mol mol-1)
1.56 ± 0.03c 1.5
Glycerol yield on sugar
(mol mol-1)
0.14 ± 0.00e 0.1
#Results are represented as average ±mean deviations of data from independent d
(a,a, b,b, etc.) are considered statistically different in a standard t-test (p <0.02).
*Detection limit of enzyme activity assay.its in vivo activity in the nitrogen-sparged cultures, add-
itional chemostats were sparged with a 10%/90% blend of
CO2 and N2. Indeed, this CO2 supplementation resulted
in a further decrease of the glycerol yield to a value below
10% of that of the reference strain (Table 1). Co-
expression of Rubisco and chaperones without co-
expression of PRK (strain IMC014) did not result in de-
creased glycerol yield (0.13 mol mol-1) compared to the
reference strain IMU032 (0.12 mol mol-1) in carbon-
limited chemostat cultures supplemented with CO2. This
observation confirmed that expression of a heterologous
phosphoribulokinase (PRK) gene is required for in vivo
carbon fixation via Rubisco in yeast.Carbon dioxide as electron acceptor in anaerobic batch
fermentations
Since industrial-scale ethanol production is routinely
performed in batch fermentations [25], the impact of the
expression of PRK and Rubisco was also investigated in
anaerobic, CO2-supplemented batch cultures (Figure 3).
Galactose was used as the carbon source for these exper-
iments to enable efficient expression of PRK from the
GAL1 promoter. Despite an almost 10 h difference in
the lag phase, the specific growth rates of the engineered
and reference strains on galactose in these anaerobic
cultures were not significantly different (Figure 3) and in
good agreement with values reported elsewhere for this
yeast strain family [26]. Consistent with the observations
in chemostat cultures, expression of the two Calvin cycle
enzymes reduced glycerol formation in the batch cul-
tures by 60% and increased the ethanol yield on galact-
ose by 8% (Figure 3e-f ). However, the biomass yielding PRK and Rubisco and the isogenic reference strain
rate of 0.05 h-1 on a synthetic medium (pH 5)
as carbon sources#
IMU033
(Expressing PRK and Rubisco)
10 0 10
.8 ± 0.0 1.02 ± 0.00 10.8 ± 0.1
1 ± 0.12 14.4 ± 1.5 15.2 ± 1.0
< 0.2 4.59 ± 0.30 2.67 ± 0.28
4 ± 0.000b 0.093 ± 0.001a 0.095 ± 0.000b
6 ± 0.02d 1.73 ± 0.02c 1.73 ± 0.01d
2 ± 0.00f 0.04 ± 0.00e, g 0.01 ± 0.00f, g
uplicate chemostat experiments. Data pairs labelled with the same subscripts
Figure 3 Physiological impact of expression of Calvin cycle enzymes on growth, substrate consumption and product formation in
galactose-grown anaerobic batch cultures of S. cerevisiae. a: growth curves of isogenic reference strain S. cerevisiae IMU032, b: growth curves of
S. cerevisiae IMU033 expressing PRK and Rubisco. Growth conditions: T = 30°C, pH 5.0, 10% CO2 in inlet gas. Each graph represents values for one of
two independent replicate experiments, whose growth kinetic parameters differed by less than 5%. c-f: Calculated parameters: Maximum specific
growth rate (c), biomass yield (d), glycerol yield (e), and ethanol yield (f) on galactose of the isogenic S. cerevisiae reference (black bars) and strain
expressing PRK and Rubisco (white bars). Results are represented as average ±mean deviations of data from independent duplicate cultures. Values
inside the white bars represent statistically significant differences in a standard t-test (p value < 0.02) relative to the reference strain.
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according to the predictions, did not increase in the an-
aerobic batch cultures on galactose. These observations
together might indicate that under the galactose excess
conditions used for these batch cultivations increased
expression levels of PRK result in a small metabolic bur-
den, but still result in an overall positive effect on the
ethanol yield.Conclusions
This study provides a compelling proof of principle for
the replacement of glycerol formation as the predomin-
ant redox sink in anaerobic yeast metabolism by PRK-
and Rubisco-mediated incorporation of CO2 into yeast
central carbon metabolism. The loss of sugar feedstock
due to glycerol production in industrial bioethanol pro-
cesses has been estimated at 4% of the consumed sugar
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strains were to completely eliminate this loss, this could
enable an additional production of 5 billion liters of
ethanol from the amount of sugar used for the 2011 glo-
bal ethanol production of 110 billion liters [1]. Use of
CO2 as an external electron acceptor offers important
advantages over previously proposed strategies for redu-
cing glycerol production in yeast-based bioethanol pro-
duction. Optimizing the redox cofactor specificity of
nitrogen assimilation in S. cerevisiae [5] only enables a
partial reduction of glycerol production and its impact
further depends on the nitrogen sources present in
industrial feedstocks. Similarly, a metabolic engineering
strategy that enables NADH-dependent reduction of
acetic acid [6] to ethanol is dependent on the presence
of acetic acid in industrial feedstocks. Further opti-
mization of PRK and Rubisco gene expression and regu-
lation in S. cerevisiae should enable the design and
construction of DNA cassettes that can be easily intro-
duced in the genomes of industrial yeast strains. This
should include the replacement of the GAL1-promotor,
that was used for the expression of PRK in this study, by
a promotor that is compatible with fast growth at high
glucose concentrations and that further balances the
expression of PRK and Rubisco. Since ribulose-5-phos-
phate is also an intermediate in pentose metabolism by
engineered S. cerevisiae strains [27], this approach
should also be readily applicable to the yeast-based
conversion of lignocellulosic hydrolysates. The observed
stimulatory effect of CO2 on the engineered strains will
not hinder application of this concept in industrial
bioethanol production, since large-scale processes for
bioethanol production are characteristically CO2 saturated.
Our results illustrate how metabolic engineering strat-
egies based on the functional integration of extensively
studied reactions in the central carbon metabolism of
distantly related organisms enables the optimization of
product yields in industrial biotechnology. Although the
present study focuses on ethanol production by yeast,
functional integration of autotrophic carbon-fixing en-
zymes in the metabolic networks of industrial microor-
ganisms should also enable optimization of yields of
other existing and novel products whose synthesis re-
sults in a net positive ATP yield.
Methods
Construction of expression modules
Phosphoribulokinase (PRK) cDNA from Spinacia oleracea
(spinach) [9] (accession number: X07654.1) was PCR-
amplified using Phusion Hot-Start Polymerase (Finnzymes,
Landsmeer, the Netherlands) and the oligonucleotides
XbaI_prk_FW2 and RV1_XhoI_prk (Table 2), and was li-
gated in pCR®-Blunt II-TOPO® (Life Technologies Europe
BV, Bleiswijk, the Netherlands). After restriction by XbaIand XhoI, the PRK-containing fragment was ligated into
pTEF424 [28]. The TEF1p was later replaced by GAL1p
from plasmid pSH47 [29] by XbaI and SacI restriction/
ligation, creating plasmid pUDE046 (Table 3).
Rubisco form II gene cbbM from T. denitrificans [17]
flanked by KpnI and SacI sites was codon optimized [30]
(accession number: KC699554), synthesized at GeneArt
(Life Technologies Europe BV), and ligated into pPCR-
Script. The cbbM-containing fragment was ligated into
the BamHI and SacI restricted vector pGPD_426 [28]
creating plasmid pBTWW002. The cbbM expression
cassette was transferred into pRS416 using KpnI and
SacI, yielding pUDC098.
Expression cassette of the specific Rubisco form II
chaperones from T. denitrificans cbbQ2 and cbbO2 [20],
and chaperones groEL and groES [18] from E. coli were
codon optimized [30] (accession numbers: KC699555
and KC699556, respectively). The expression cassettes
contained a yeast constitutive promoters and terminator,
flanking the codon optimized gene. The cassette was
flanked by unique 60-bp regions obtained by randomly
combining bar-code sequences used in the Saccharomyces
Genome Deletion Project [31] and an EcoRV site
(GeneArt). The expression cassettes were inserted in
plasmid pMK-RQ (GeneArt) using the SfiI cloning
sites yielding pUD230 (PGI1p-cbbQ2-TEF2t), pUD231
(PGK1p-cbbO2-ADH1t), pUD232 (TEF1p-groEL-ACT1t),
and pUDE233 (TPI1p-groES-PGI1t) (Table 3). The expres-
sion cassette TDH3p-cbbM-CYC1t was PCR-amplified
from plasmid pBTWW002 using Phusion Hot-Start
Polymerase (Finnzymes) and primers HR-cbbM-FW-65
and HR-cbbM-RV-65 in order to incorporate the 60-bp
region for recombination cloning.
Strain construction, isolation and maintenance
All Saccharomyces cerevisiae strains used (Table 4) belong
to the CEN.PK family [32,33]. All strains were grown in
2% w/v glucose synthetic media [7] supplemented with
150 mg l-1 uracil when required [34] until they reached
end exponential phase, then sterile glycerol was added up
to ca. 30% v/v and aliquot of 1 ml were stocked −80°C.
The strain IMC014 that co-expressed the Rubisco form
II cbbM and the four chaperones cbbQ2, cbbO2, groEL,
and groES was constructed using a previously published
in vivo transformation associated recombination [35]. 200
fmol of each expression cassette were pooled with 100
fmol of the KpnI/SacI linearized pRS416 backbone in a
final volume of 50 μl and transformed in CEN.PK 113-5D
using the lithium acetate protocol [36] (Figure 4a). Cells
were selected on synthetic medium. Correct assembly of
the fragment of pUDC075 was performed by multiplex
PCR on transformant colonies using primers enabling
amplification over the regions used for homologous recom-
bination (Table 2) and by restriction analysis after
Table 2 Oligonucleotides used in this study
Number Name Sequence (5′ to 3′) Purpose
Cloning
1 XbaI_prk_FW2 TGACATCTAGATGTCACAACAACAAACAATTG Cloning of PRK into pUDE046.
2 RV1 XhoI prk TGACATCTAGATGTCACAACAACAAACAATTG Cloning of PRK into pUDE046.




















Linker fragment for assembly of plasmid pUDC100.





1st cloning expression cassette linker fragment between CAN1 upstream and PRK






1st cloning fragment: linker fragment between CAN1up-linker and PRK expression
cassette (IMI229).
9 RV linker-iHR6 GCTATGACCATGATTACGCCAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGGTTG
CGCTAAGAGAATGGACC
















GACATATCAGCATACATGGCTATGG 3rd cloning fragment: PGI1p-cbbQ2-TEF2t cassette (IMI229).
13 RV HR2-
cbbQ2-HR3
GGACACGCTTGACAGAATGTCAAAGG 3rd cloning fragment: PGI1p-cbbQ2-TEF2t cassette (IMI229).
14 FW HR3-
cbbO2-HR4
CGTCCGATATGATCTGATTGG 4th cloning fragment: PGK1p-cbbO2-ADH1t cassette (IMI229).
15 RV HR3-
cbbO2-HR4
CCTAGAAATCTCGTCGATCTC 4th cloning fragment: PGK1p-cbbO2-ADH1t cassette (IMI229).
16 FW HR4-
GroEL-HR5
ATCACTCTTACCAGGCTAGG 5th cloning fragment: TEF1p-groEL-ACT1t cassette (IMI229).
17 RV HR4-GroEL-
HR5
CTGGACCTTAATCGTGTGCGCATCCTC 5th cloning fragment: TEF1p-groEL-ACT1t cassette (IMI229).
18 FW HR5-
GroES-HR6


















Table 2 Oligonucleotides used in this study (Continued)
19 RV HR5-GroES-
HR6





7th (IMI229) or 2nd (IMI232) cloning fragment: KlLEU2 cassette from pUG73.




7th (IMI229) or 2nd (IMI232) cloning fragment: KlLEU2 cassette from pUG73.
Primers used for verification of the in vivo assembled constructs
22 m-PCR-HR1-
FW
GGCGATTAAGTTGGGTAACG Diagnostic for assembly of plasmids pUDC075, pUDC099, and pUDC100, and
integration in strain IMI229.
23 m-PCR-HR1-
RV
AACTGAGCTCCAGCTGTACC Diagnostic for assembly of plasmids pUDC075, pUDC099, pUDC100, and
integration in strain IMI229.
24 m-PCR-HR2-
FW
































































MATa ura3-52 leu2-3, 112 Euroscarf.





IMC033 MATa ura3-52 pUDC098 (CEN6 ARS4 URA3
TDH3p-cbbM-CYC1t)
This study.












IMI232 MATa ura3-52 leu2-3, 112 can1::KlLEU2 This study.
IMU032 IMI232 p426_GPD (2μ URA3) This study.
IMU033 IMI229 pUDC100 (CEN6 ARS4 URA3 TEF1p-groEL-
ACT1t TPI1p-groES-PGI1t cbbM-GroEL linker)
This study.
Table 3 Plasmids used in this study
Name Relevant genotype Source/reference
pFL451 AOX1p-prk (Spinach)-AOX1t (pHIL2-
D2 HIS4 Amp centromeric)





pTEF424_TEF TRP1 2μ bla Mumberg et al. [28].
pSH47 URA3 CEN6 ARS4 GAL1p-cre-CYC1t
bla
Güldener et al. [29].
pUD0E46 TRP1 2μ GAL1p-prk-CYC1t bla This study.
pPCR-Script Bla Life Technologies
Europe BV.
pGPD_426 URA3 2μ bla Mumberg et al. [28].
pRS416 URA3 CEN6 ARS4 bla Mumberg et al. [28].
pBTWW002 URA3 2μ TDH3p-cbbM-CYC1t bla This study.
pUDC098 URA3 CEN6 ARS4 TDH3p-cbbM-CYC1t
bla
This study.
pMK-RQ nptII Life Technologies
Europe BV.
pUD230 PGI1p-cbbQ2-TEF2t nptII Life Technologies
Europe BV.
pUD231 PGK1p-cbbO2-ADH1t nptII Life Technologies
Europe BV.
pUD232 TEF1p-groEL-ACT1t nptII Life Technologies
Europe BV.
pUD233 TPI1p-groES-PGI1t nptII Life Technologies
Europe BV.
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pUDC075 was sequenced by Next Gen Seq Illumina (100-
bp reads paired-end, 50Mb) and assembled with Velvet
[37]. The assembled sequence did not contain mutations in
any of the assembled expression cassettes. The strains
IMC034 and IMC035 that expressed cbbM/cbbQ2/cbbO2
and cbbM/groEL/groES respectively were constructed using
the same in vivo assembly method with the following modi-
fication. To construct plasmids pUDC099 and pUDC100,
120 bp cbbO2-pRS416 linker and cbbM-GroEL linker were
used to close the assembly respectively (Table 2), 100 fmol
of each of complementary 120 bp oligonucleotides were
added to the transformation. The strain IMC033 that only
expressed the cbbM gene was constructed by transforming
CEN.PK113-5D with pUDC098.To construct the strain IMU033 that co-expressed PRK,
cbbM, cbbQ2, cbbO2, the intermediate strain IMI229 was
constructed by integrating PRK, the four chaperones and
KlLEU2 [38] at the CAN1 locus by in vivo homologous in-
tegration in CEN.PK102-3A (Figure 4b). The expression
cassettes were PCR amplified using Phusion Hot-Start
Polymerase (Finnzymes), the corresponding oligonucleo-
tides and DNA templates (Table 2). Finally, the strain
IMI229 was transformed with pUDC100 that carries the
Rubisco form II cbbM and the two E. coli chaperones
groEL and groES.
Strain IMI232 was constructed by transforming CEN.
PK102-3A with the KlLEU2 cassette. IMI232 was finally
transformed with the plasmid p426GPD to restore pro-
totrophy resulting in the reference strain IMU032.
Experimental set-up of chemostat and batch experiments
Anaerobic chemostat cultivation was performed essentially
as described [39] but with 12.5 g l-1 glucose and 12.5 g l-1
galactose as the carbon source and where indicated, a mix-
ture of 10% CO2/90% N2 replaced pure nitrogen as the
sparging gas. Residual glucose and galactose concentrations
were determined after rapid quenching [40] using commer-
cial enzymatic assays for glucose (Boehringer, Mannheim,
Germany) and D-galactose (Megazyme, Bray, Ireland). An-
aerobic bioreactor batch cultures were grown essentially as
described [6], but with 20 g l-1 galactose and a sparging gas
Figure 4 Strategy for the heterologous expression of Rubisco and PRK in S. cerevisiae. (a) In vivo assembly of Rubisco expression plasmid
pUDC075, and (b) in vivo assembly and integration of PRK and chaperone proteins in CAN1 locus of Saccharomyces cerevisiae strain IMI229. Each
fragment represents a different expression cassette or plasmid backbone. All fragments used in assembly experiments were flanked by 60-bp
sequences used for in vivo recombination, either enabling the assembly of plasmids or the integration assembled constructs into the S. cerevisiae
genome. Arrows and numbers indicate primers used in the construction of the cassette.
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ite concentrations in batch and chemostat and batch cul-
tures were determined as described by Guadalupe et al. [6].
In calculations of ethanol fluxes and yields, ethanol evapor-
ation was corrected for based on a first-order evaporation
rate constant of 0.008 h-1 in the bioreactor setups and
under the conditions used in this study [6,39].Enzyme assays for phosphoribulokinase and Rubisco
Cell extracts for analysis of phosphoribulokinase (PRK)
activity were prepared as described previously [41]. PRK
activity was measured at 30°C by a coupled spectro-
photometric assay [42]. Reaction rates were proportional tothe amounts of cell extract added. Protein concentrations
were determined by the Lowry method [43] using bovine
serum albumin as a standard.
Cell extracts for Rubisco activity assays were prepared
as described [41], with two modifications: Tris–HCl
(1 mM, pH 8.2) containing 20 mM MgCl2•6H2O, 5 mM
of DTT and 5 mM NaHCO3 was used as sonication buffer
and Tris–HCl (100 mM, pH 8.2), 20 mM MgCl2•6H2O
and 5 mM of DTT as freezing buffer. Rubisco activity was
determined by measuring 14CO2-fixation (PerkinElmer,
Groningen, The Netherlands) as described [44] and meas-
uring radioactive counts in a TRI-CARB® 2700TR Series li-
quid scintillation counter (PerkinElmer, Groningen, The
Netherlands), using Ultima Gold™ scintillation cocktail
Guadalupe-Medina et al. Biotechnology for Biofuels 2013, 6:125 Page 11 of 12
http://www.biotechnologyforbiofuels.com/content/6/1/125(PerkinElmer, Groningen, The Netherlands). Protein con-
centrations were determined by the Lowry method [43]
using standard solutions of bovine serum albumin
dissolved in 50 mM Tris–HCl (pH 8.2).
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